- Home
- OBIO vs IDR Comparison
OBIO vs IDR Comparison
Compare OBIO & IDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- IDR
- Stock Information
- Founded
- OBIO 2017
- IDR 1996
- Country
- OBIO United States
- IDR United States
- Employees
- OBIO N/A
- IDR N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- IDR Precious Metals
- Sector
- OBIO Health Care
- IDR Basic Materials
- Exchange
- OBIO Nasdaq
- IDR Nasdaq
- Market Cap
- OBIO 200.1M
- IDR 164.1M
- IPO Year
- OBIO N/A
- IDR N/A
- Fundamental
- Price
- OBIO $5.84
- IDR $11.03
- Analyst Decision
- OBIO Strong Buy
- IDR Strong Buy
- Analyst Count
- OBIO 4
- IDR 1
- Target Price
- OBIO $15.75
- IDR $14.00
- AVG Volume (30 Days)
- OBIO 57.1K
- IDR 328.1K
- Earning Date
- OBIO 11-12-2024
- IDR 11-04-2024
- Dividend Yield
- OBIO N/A
- IDR N/A
- EPS Growth
- OBIO N/A
- IDR 344.27
- EPS
- OBIO N/A
- IDR 0.52
- Revenue
- OBIO $2,647,000.00
- IDR $21,955,008.00
- Revenue This Year
- OBIO $7.68
- IDR $100.42
- Revenue Next Year
- OBIO $110.40
- IDR $4.80
- P/E Ratio
- OBIO N/A
- IDR $21.28
- Revenue Growth
- OBIO N/A
- IDR 64.93
- 52 Week Low
- OBIO $4.22
- IDR $4.84
- 52 Week High
- OBIO $11.69
- IDR $18.35
- Technical
- Relative Strength Index (RSI)
- OBIO 51.19
- IDR 30.57
- Support Level
- OBIO $5.56
- IDR $10.72
- Resistance Level
- OBIO $6.50
- IDR $11.83
- Average True Range (ATR)
- OBIO 0.53
- IDR 1.21
- MACD
- OBIO 0.00
- IDR -0.51
- Stochastic Oscillator
- OBIO 56.58
- IDR 4.21
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About IDR Idaho Strategic Resources Inc.
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.